On 21st July, 2021 the CDC gave out a Laboratory Alert revoking the EUA for RT-PCR tests to detect SARS-COV-2.
“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.”
The CDC also recommended clinical laboratories and testing sites using RT-PCR to transition to another FDA-authorized COVID-19 test.
“In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.”
Numerous courts around the world have determined the use of RT-PCR for detection of SARS-COV-2 as unreliable and downright fraudulent....<<<Read More...>>>...
